683 Capital Management’s Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-335,754
| Closed | -$107K | – | 135 |
|
|
2025
Q1 | $107K | Sell |
335,754
-159,921
| -32% | -$51.2K | 0.01% | 110 |
|
|
2024
Q4 | $114K | Sell |
495,675
-100
| -0% | -$23 | 0.01% | 201 |
|
|
2024
Q3 | $48.5K | Sell |
495,775
-112,908
| -19% | -$11.1K | ﹤0.01% | 103 |
|
|
2024
Q2 | $97.4K | Sell |
608,683
-2,040
| -0.3% | -$326 | 0.01% | 98 |
|
|
2024
Q1 | $185K | Sell |
610,723
-224,600
| -27% | -$67.9K | 0.01% | 88 |
|
|
2023
Q4 | $50.1K | Hold |
835,323
| – | – | ﹤0.01% | 206 |
|
|
2023
Q3 | $83.5K | Hold |
835,323
| – | – | 0.01% | 93 |
|
|
2023
Q2 | $138K | Hold |
835,323
| – | – | 0.01% | 93 |
|
|
2023
Q1 | $100K | Hold |
835,323
| – | – | 0.01% | 201 |
|
|
2022
Q4 | $121K | Hold |
835,323
| – | – | 0.01% | 219 |
|
|
2022
Q3 | $167K | Hold |
835,323
| – | – | 0.01% | 144 |
|
|
2022
Q2 | $234K | Hold |
835,323
| – | – | 0.02% | 167 |
|
|
2022
Q1 | $674K | Buy |
835,323
+10,000
| +1% | +$8.07K | 0.04% | 174 |
|
|
2021
Q4 | $1.56M | Hold |
825,323
| – | – | 0.06% | 134 |
|
|
2021
Q3 | $2.11M | Hold |
825,323
| – | – | 0.08% | 102 |
|
|
2021
Q2 | $2.15M | Hold |
825,323
| – | – | 0.07% | 111 |
|
|
2021
Q1 | $2.2M | Buy |
+825,323
| New | +$2.2M | 0.12% | 89 |
|